Biotech Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Adventrx Pharmaceuticals, Inc.
Adventrx signs definitive merger agreement with SD Pharmaceuticals
May 8th, 2006
Adventrx Pharmaceuticals, Inc., (ANX) and SD Pharmaceuticals, Inc., (SD Pharma) have signed a definitive merger agreement whereby Adventrx will acquire all of the outstanding shares of SD Pharma. Under the terms of the agreement, Adventrx will issue, and SD Pharma stockholders will receive, approximately 2,100,000 shares of Adventrx common stock. The agreement and plan of merger has been approved by the boards of directors of both companies and by the stockholders of SD Pharma. The closing of the merger is subject to the fulfillment of a number of conditions which the parties currently expect will be satisfied. SD Pharma co-founder, Andrew Chen, PhD, RPh, will continue...
Source: Biotech Week (2006-05-08)
|
